{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:39:50Z","timestamp":1788982790906,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,12,27]],"date-time":"2014-12-27T00:00:00Z","timestamp":1419638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s13277-014-2996-4","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T17:10:19Z","timestamp":1419613819000},"page":"3591-3599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA\/BRCA pathway"],"prefix":"10.1007","volume":"36","author":[{"given":"Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Guo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,27]]},"reference":[{"key":"2996_CR1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.mcp.0000166590.03042.56","volume":"11","author":"SG Spira","year":"2005","unstructured":"Spira SG, Silvestri GA. The treatment of advanced non-small cell lung cancer. Curr Opin Pulm Med. 2005;11:287\u201391.","journal-title":"Curr Opin Pulm Med"},{"issue":"suppl 1","key":"2996_CR2","doi-asserted-by":"crossref","first-page":"s9","DOI":"10.1053\/j.seminoncol.2005.12.007","volume":"33","author":"E Massarelli","year":"2006","unstructured":"Massarelli E, Herbst RS. Use of novel second-line target therapies in non-small cell lung cancer. Semin Oncol. 2006;33 suppl 1:s9\u201316.","journal-title":"Semin Oncol"},{"key":"2996_CR3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMra035536","volume":"350","author":"A Spira","year":"2004","unstructured":"Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350:379\u201392.","journal-title":"N Engl J Med"},{"key":"2996_CR4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.coph.2006.01.011","volume":"6","author":"R Resell","year":"2006","unstructured":"Resell R, Cecere F, Santarpia M, Noemi R, Miquel T. Predicting the outcome of chemotherapy for lung cancer. Curr Opin Pharmacol. 2006;6:323\u201331.","journal-title":"Curr Opin Pharmacol"},{"key":"2996_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0027-5107(01)00141-5","volume":"478","author":"M Kartalou","year":"2001","unstructured":"Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res. 2001;478:23\u201343.","journal-title":"Mutat Res"},{"key":"2996_CR6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7:573\u201384.","journal-title":"Nat Rev Cancer"},{"key":"2996_CR7","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1200\/JCO.2005.05.4171","volume":"24","author":"RD Kennedy","year":"2006","unstructured":"Kennedy RD, D\u2019Andrea AD. DNA repair pathway in clinical practice: lesions from pediatric cancer susceptibility syndromes. J Clin Oncol. 2006;24:3799\u2013808.","journal-title":"J Clin Oncol"},{"key":"2996_CR8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1101\/gad.195248.112","volume":"26","author":"H Kim","year":"2012","unstructured":"Kim H, D\u2019Andrea AD. Regulation of DNA Cross-link repair by the Fanconi anemia\/BRCA pathway. Genes Dev. 2012;26:1393\u2013408.","journal-title":"Genes Dev"},{"key":"2996_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mrfmmm.2009.01.013","volume":"668","author":"AD Auerbach","year":"2009","unstructured":"Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res. 2009;668:4\u201310.","journal-title":"Mutat Res"},{"key":"2996_CR10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMra0809889","volume":"362","author":"D Alan","year":"2010","unstructured":"Alan D. The Fanconi anemia and breast susceptibility pathway. N Engl J Med. 2010;362:1909\u201319.","journal-title":"N Engl J Med"},{"key":"2996_CR11","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1101\/gad.1955310","volume":"24","author":"Y Kee","year":"2010","unstructured":"Kee Y, D\u2019Andrea AD. Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev. 2010;24:1680\u201394.","journal-title":"Genes Dev"},{"key":"2996_CR12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s13238-011-1098-y","volume":"2","author":"X Su","year":"2011","unstructured":"Su X, Huang J. The Fanconi anemia pathway and DNA interstrand cross-link repair. Protein Cell. 2011;2:704\u201311.","journal-title":"Protein Cell"},{"key":"2996_CR13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm852","volume":"9","author":"T Taniguchi","year":"2003","unstructured":"Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 2003;9:568\u201374.","journal-title":"Nat Med"},{"key":"2996_CR14","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature06633","volume":"451","author":"W Sakai","year":"2008","unstructured":"Sakai W, Swisher EM, Karlan BY, Agarwal MK, Higgins J, Friedman C, et al. Secondary mutations as a mechanism of cisplatin resistance in BRCA-mutated cancers. Nature. 2008;451:1116\u201320.","journal-title":"Nature"},{"key":"2996_CR15","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2174\/092986709787909578","volume":"16","author":"S Jagtap","year":"2009","unstructured":"Jagtap S, Meganathan K, Wagh V, Winkler J, Hescheler J, Sachinidis A. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem. 2009;16:1451\u201362.","journal-title":"Curr Med Chem"},{"key":"2996_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.currproblcancer.2007.04.001","volume":"31","author":"S Shishodia","year":"2007","unstructured":"Shishodia S, Chalurvedi MM, Aggarwal BB. Role of curcumin in cancer therapy. Curr Probl Cancer. 2007;31:243\u2013305.","journal-title":"Curr Probl Cancer"},{"key":"2996_CR17","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.3390\/ijms13033959","volume":"13","author":"MX Ye","year":"2012","unstructured":"Ye MX, Li Y, Yin H, Zhang J. Curcumin: updated molecular mechanisms and intervention targets in human lung cancer. Int J Mol Sci. 2012;13:3959\u201378.","journal-title":"Int J Mol Sci"},{"key":"2996_CR18","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1158\/1535-7163.MCT-10-0064","volume":"9","author":"VM Duarte","year":"2010","unstructured":"Duarte VM, Han E, Veena MS, Salvado A, Suh JD, Liang LJ, et al. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKK\u03b2 protein of the NF\u03baB pathway. Mol Cancer Ther. 2010;9:2665\u201375.","journal-title":"Mol Cancer Ther"},{"key":"2996_CR19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.gene.2014.06.006","volume":"546","author":"XB Xu","year":"2014","unstructured":"Xu XB, Chen B, Liu WY. Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K\/kt signaling pathway. Gene. 2014;546:226\u201332.","journal-title":"Gene"},{"key":"2996_CR20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2174\/1871520614666140521114735","volume":"14","author":"S Zang","year":"2014","unstructured":"Zang S, Liu T, Shi J, Qiao L. Curcumin: a promising agent targeting cancer stem cells. Anticancer Agents Med Chem. 2014;14:787\u201392.","journal-title":"Anticancer Agents Med Chem"},{"key":"2996_CR21","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1535-7163.MCT-05-0493","volume":"5","author":"D Chirnomas","year":"2006","unstructured":"Chirnomas D, Taniguchi T, de la Vaga M, Vaidya AP, Vasserman M, Hartman A-R, et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia\/BRCA pathway. Mol Cancer Ther. 2006;5:952\u201361.","journal-title":"Mol Cancer Ther"},{"key":"2996_CR22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00277-009-0831-6","volume":"89","author":"H Xiao","year":"2010","unstructured":"Xiao H, Xiao Q, Zhang K, Zuo X, Shresthan UK. Reversal of multidrug resistance by curcumin through FA\/BRCA pathway in multiple myeloma cell line MOLP-2\/R. Ann Hematol. 2010;89:399\u2013404.","journal-title":"Ann Hematol"},{"key":"2996_CR23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ijc.10183","volume":"98","author":"Z-M Shao","year":"2002","unstructured":"Shao Z-M, Shen Z-Z, Liu C-H, Sartippour MR, Heber D, Nguyen M. Curcumin exerts multiples suppressive effects on human breast carcinoma cells. Int J Cancer. 2002;98:234\u201340.","journal-title":"Int J Cancer"},{"key":"2996_CR24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood-2004-11-4286","volume":"106","author":"Q Chen","year":"2005","unstructured":"Chen Q, Van der Sluis PC, Boulware D, Hazlehurst LA, Dalton WS. The FA\/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells. Blood. 2005;106:698\u2013705.","journal-title":"Blood"},{"key":"2996_CR25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0002-9440(10)63329-9","volume":"165","author":"MS Heijden van der","year":"2004","unstructured":"van der Heijden MS, Brody JR, Gallemier E, Cunningham SC, Dezentje DA, Shen D, et al. Function defects in the Fanconi anemia pathway in pancreatic cancer cells. Am J Pathol. 2004;165:651\u20137.","journal-title":"Am J Pathol"},{"key":"2996_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2007.01.017","volume":"8","author":"K Burkitt","year":"2007","unstructured":"Burkitt K, Ljungman M. Compromised Fanconi anemia response due to BRCA1 deficiency in cisplatin-sensitive head and neck cancer cell lines. Cancer Lett. 2007;8:131\u20137.","journal-title":"Cancer Lett"},{"key":"2996_CR27","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4161\/cbt.5.12.3351","volume":"5","author":"J Zhang","year":"2006","unstructured":"Zhang J, Wang X, Lin C-J, Conch FJ, Fei P. Altered expression of FANCL confers mitomycin C sensitivity in calu-6 lung cancer cells. Cancer Biol Ther. 2006;5:1632\u20136.","journal-title":"Cancer Biol Ther"},{"key":"2996_CR28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-7-24","volume":"7","author":"K Burkitt","year":"2008","unstructured":"Burkitt K, Ljurgman M. Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitized head and neck cancer cells to cisplatin. Mol Cancer. 2008;7:24.","journal-title":"Mol Cancer"},{"key":"2996_CR29","doi-asserted-by":"crossref","first-page":"9367","DOI":"10.1158\/0008-5472.CAN-09-2616","volume":"69","author":"DN Yarde","year":"2009","unstructured":"Yarde DN, Oliveira V, Mathews L, Wang X, Villagra A, Boulware D, et al. Targeting the Fanconi anemial BRCA pathway circumvents drug resistance in multiple myeloma. Cancer Res. 2009;69:9367\u201375.","journal-title":"Cancer Res"},{"key":"2996_CR30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.chembiol.2011.08.014","volume":"18","author":"J Chen","year":"2011","unstructured":"Chen J, Dexheimer TS, Ai Y, Liang G, Villamil MA, Inglese J, et al. Selective and cell-active inhibitors of the USP1\/UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells. Chem Biol. 2011;18:1390\u2013400.","journal-title":"Chem Biol"},{"key":"2996_CR31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1541-7786.MCR-11-0497","volume":"10","author":"Y Kee","year":"2012","unstructured":"Kee Y, Huang M, Chang S, Moreau LA, Park E, Smith PG, et al. Inhibition of the Nedd8 system sensitive cells to DNA interstrand cross-linking agents. Mol Cancer Res. 2012;10:369\u201377.","journal-title":"Mol Cancer Res"},{"key":"2996_CR32","first-page":"423","volume":"8","author":"R Litan","year":"2008","unstructured":"Litan R, Gupta R, Brosh Jr RM, Cantor SB. BRCA-FA pathway as a target for anti-tumor drugs. Anticancer Agents Med Chem. 2008;8:423\u201330.","journal-title":"Anticancer Agents Med Chem"},{"key":"2996_CR33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.33549\/physiolres.932115","volume":"60","author":"T Hucl","year":"2011","unstructured":"Hucl T, Gallmeier E. DNA repair: exploiting the Fanconi anemia pathway as a potential therapeutic target. Physiol Res. 2011;60:453\u201365.","journal-title":"Physiol Res"},{"key":"2996_CR34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/ejh.12169","volume":"9","author":"P Shukl","year":"2013","unstructured":"Shukl P, Solank A, Ghos K, Vundinit BR. DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications. Eur J Haematol. 2013;9:381\u201393.","journal-title":"Eur J Haematol"},{"key":"2996_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","volume":"269","author":"AB Kunnunakkara","year":"2008","unstructured":"Kunnunakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling protein. Cancer Lett. 2008;269:199\u2013255.","journal-title":"Cancer Lett"},{"key":"2996_CR36","first-page":"1197","volume":"26","author":"LL Yu","year":"2011","unstructured":"Yu LL, Wu JG, Dai HG, Si JM. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-Kappa B transcritption factor. Oncol Rep. 2011;26:1197\u2013203.","journal-title":"Oncol Rep"},{"key":"2996_CR37","doi-asserted-by":"crossref","first-page":"11680","DOI":"10.1074\/jbc.M310369200","volume":"219","author":"NR Jana","year":"2004","unstructured":"Jana NR, Diskshit P, Goswami A, Nukina N. Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem. 2004;219:11680\u20135.","journal-title":"J Biol Chem"},{"key":"2996_CR38","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1158\/0008-5472.CAN-07-1015","volume":"67","author":"C Jacquemont","year":"2007","unstructured":"Jacquemont C, Taniguchi T. Proteasome function is required for DNA damage response and Fanconi anemia pathway activation. Cancer Res. 2007;67:7395\u2013405.","journal-title":"Cancer Res"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2996-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2996-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T11:46:58Z","timestamp":1598615218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2996-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,27]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2996"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2996-4","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,27]]}}}